Additionally, a reduction in tumor volumes and the Ki67 proliferation index, an increase in apoptosis, and an increase in animal survival rates make TMZ and PF-562271 combinatorial treatment a potential strategy for GBM. The gene discussed is MKI67; the disease is glioblastoma.